Gefitinib in a molecularly defined chemonaive population with advanced non-small-cell lung cancer

被引：1
|
作者：
Teck, Lim Wan [1 ]
Huat, Tan Bee [1 ]
Ravindran, Kanesvaran [1 ]
Balram, Chowbay [1 ]
机构：
[1] Natl Canc Ctr S, Div Med Sci, Clin Pharmacol Lab, Humphrey Oei Inst Canc Res, Singapore 169610, Singapore
来源：
PHARMACOGENOMICS | 2008年 / 9卷 / 10期
关键词：
D O I：
10.2217/14622416.9.10.1381
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1381 / 1382
页数：2
相关论文
共 50 条
  • [31] Biomarkers of response to gefitinib in non-small-cell lung cancer
    Carbone, David P.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 66 - 67
  • [32] Gefitinib plus clocetaxel in non-small-cell lung cancer
    Costa, Daniel B.
    Kobayashi, Susumu
    LANCET, 2009, 373 (9663): : 541 - 541
  • [33] Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
    Cataldo, Vince D.
    Gibbons, Don L.
    Perez-Soler, Roman
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 947 - 955
  • [34] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY
    Cataldo, Vince D.
    Gibbons, Don L.
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2368 - 2368
  • [35] Biomarkers of response to gefitinib in non-small-cell lung cancer
    David P Carbone
    Nature Clinical Practice Oncology, 2004, 1 : 66 - 67
  • [36] Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
    Martin J. Edelman
    Heather Quam
    Brian Mullins
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 141 - 144
  • [37] Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
    Edelman, MJ
    Quam, H
    Mullins, B
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 141 - 144
  • [38] Advanced Non-Small-Cell Lung Cancer
    Kwon, Hyun W.
    Ham, Soo-Youn
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1997 - +
  • [39] Effect of EGFR mutations on gefitinib in advanced previous treated non-small-cell lung cancer
    Guo, J.
    Zhou, C.
    Deng, Q.
    Ren, S.
    Zhang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status
    Chang, GC
    Chen, KC
    Yang, TY
    Yin, MC
    Lin, CP
    Kuo, BIT
    Hsu, JY
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (01) : 73 - 77
12345